These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 18447602

  • 21. Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniae.
    Saravolatz L, Manzor O, Pawlak J, Belian B.
    Int J Antimicrob Agents; 2005 Jul; 26(1):81-4. PubMed ID: 15951159
    [Abstract] [Full Text] [Related]

  • 22. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P, File T, Feldman C.
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [Abstract] [Full Text] [Related]

  • 23. Gemifloxacin.
    Lowe MN, Lamb HM.
    Drugs; 2000 May; 59(5):1137-47; discussion 1148. PubMed ID: 10852645
    [Abstract] [Full Text] [Related]

  • 24. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P, Mandell L, Patou G, Dankner W, Tillotson G.
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [Abstract] [Full Text] [Related]

  • 25. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
    Morrissey I, Tillotson G.
    J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
    [Abstract] [Full Text] [Related]

  • 26. Clinical effects of gemifloxacin on the delay of tuberculosis treatment.
    Kim SY, Yim JJ, Park JS, Park SS, Heo EY, Lee CH, Chung HS, Kim DK.
    J Korean Med Sci; 2013 Mar; 28(3):378-82. PubMed ID: 23486643
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.
    Hammerschlag MR.
    J Antimicrob Chemother; 2001 Nov; 48(5):735. PubMed ID: 11679567
    [No Abstract] [Full Text] [Related]

  • 28. Clinical characteristics and response to newer quinolones in Legionella pneumonia: a report of 28 cases.
    Santos J, Aguilar L, García-Méndez E, Siquier B, Custardoy J, García-Rey C, Pallarés R, Blanquer R, Caminero J, Dal-Ré R, Durán J, Gil-Aguado A, Grau I, Ibáñez D, Llorca E, Martínez J, Molinos L, Mensa J, Moreno S, Palacios R, Vidal J, 049 Cap Collaborative Study Group.
    J Chemother; 2003 Oct; 15(5):461-5. PubMed ID: 14598938
    [Abstract] [Full Text] [Related]

  • 29. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
    Vallet CM, Marquez B, Ngabirano E, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
    [Abstract] [Full Text] [Related]

  • 30. Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use.
    Frei CR, Labreche MJ, Attridge RT.
    Drugs; 2011 Apr 16; 71(6):757-70. PubMed ID: 21504252
    [Abstract] [Full Text] [Related]

  • 31. Geminofloxacin for the management of community-acquired respiratory tract infections.
    Blondeau JM, Tillotson G, Deangelis J.
    J Chemother; 2006 Dec 16; 18(6):582-8. PubMed ID: 17267335
    [Abstract] [Full Text] [Related]

  • 32. Fluoroquinolones in the management of community-acquired pneumonia.
    Albertson TE, Dean NC, El Solh AA, Gotfried MH, Kaplan C, Niederman MS.
    Int J Clin Pract; 2010 Feb 16; 64(3):378-88. PubMed ID: 20456176
    [Abstract] [Full Text] [Related]

  • 33. Convulsant activity and pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats.
    Roy B, Bose A, Bhaumik U, Das A, Chatterjee N, Ghosh A, Darbar S, Sarkar AK, Sengupta P, Pal TK.
    J Pharm Sci; 2010 Mar 16; 99(3):1535-47. PubMed ID: 19670296
    [Abstract] [Full Text] [Related]

  • 34. 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
    Roig J, Casal J, Gispert P, Gea E.
    Med Mal Infect; 2006 Mar 16; 36(11-12):680-9. PubMed ID: 17095177
    [Abstract] [Full Text] [Related]

  • 35. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM.
    Infection; 2005 Jun 16; 33(3):106-14. PubMed ID: 15940410
    [Abstract] [Full Text] [Related]

  • 36. Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
    Azoulay-Dupuis E, Bédos JP, Mohler J, Moine P, Cherbuliez C, Peytavin G, Fantin B, Köhler T.
    Antimicrob Agents Chemother; 2005 Mar 16; 49(3):1046-54. PubMed ID: 15728901
    [Abstract] [Full Text] [Related]

  • 37. Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones.
    Saravolatz LD, Leggett J.
    Clin Infect Dis; 2003 Nov 01; 37(9):1210-5. PubMed ID: 14557966
    [Abstract] [Full Text] [Related]

  • 38. Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens.
    Thabit AK, Crandon JL, Nicolau DP.
    Int J Antimicrob Agents; 2016 Nov 01; 48(5):535-541. PubMed ID: 27742208
    [Abstract] [Full Text] [Related]

  • 39. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.
    Kirkcaldy RD, Weinstock HS, Moore PC, Philip SS, Wiesenfeld HC, Papp JR, Kerndt PR, Johnson S, Ghanem KG, Hook EW.
    Clin Infect Dis; 2014 Oct 15; 59(8):1083-91. PubMed ID: 25031289
    [Abstract] [Full Text] [Related]

  • 40. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A.
    East Mediterr Health J; 2005 Oct 15; 11(1-2):36-44. PubMed ID: 16532669
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.